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ABSTRACT
The product of the Plasmodium falciparum genes
clag3.1 and clag3.2 plays a fundamental role in
malaria parasite biology by determining solute trans-
port into infected erythrocytes. Expression of the two
clag3 genes is mutually exclusive, such that a sin-
gle parasite expresses only one of the two genes
at a time. Here we investigated the properties and
mechanisms of clag3 mutual exclusion using trans-
genic parasite lines with extra copies of clag3 pro-
moters located either in stable episomes or inte-
grated in the parasite genome. We found that the
additional clag3 promoters in these transgenic lines
are silenced by default, but under strong selective
pressure parasites with more than one clag3 pro-
moter simultaneously active are observed, demon-
strating that clag3 mutual exclusion is strongly fa-
vored but it is not strict. We show that silencing of
clag3 genes is associated with the repressive histone
mark H3K9me3 even in parasites with unusual clag3
expression patterns, and we provide direct evidence
for heterochromatin spreading in P. falciparum. We
also found that expression of a neighbor ncRNA cor-
relates with clag3.1 expression. Altogether, our re-
sults reveal a scenario where fitness costs and non-
deterministic molecular processes that favor mutual
exclusion shape the expression patterns of this im-
portant gene family.
INTRODUCTION
Regulation of gene expression plays a central role in the bi-
ology of the apicomplexan parasitePlasmodium falciparum,
which is responsible for the most severe forms of human
malaria. Progression along the complex life cycle of malaria
parasites, which involves multiple well-differentiated stages,
is mainly controlled at the transcriptional level (1,2). Dy-
namic transcriptional regulation along the life cycle in-
volves transcription factor cascades (3) and also changes
at the chromatin level (4,5), although in the context of life
cycle progression the latter probably play an effector role
and do not transmit epigenetic information from one gener-
ation to the next (6). Another important process in P. falci-
parum biology controlled at the transcriptional level is clon-
ally variant gene expression. Genes under clonally variant
expression can be found in either an active or a silenced
state in genetically identical parasites at the same stage of
the life cycle. Recent research has established that disparate
P. falciparum gene families involved in different aspects of
host-parasite interactions show clonally variant expression
(7). This type of expression is believed to play an important
role in parasite survival by allowing the adaptation of par-
asite populations to changing environments by bet-hedging
adaptive strategies (7). While the main role of some large P.
falciparum clonally variant gene families is antigenic varia-
tion and immune evasion, other clonally variant genes con-
fer functional variation (7–10) or control developmental de-
cisions (11).
Clonally variant gene expression is a truly epigenetic phe-
nomenon, involving stochastic choices and transmission of
non-genetic information from one generation to the next
(6). The molecular basis for clonally variant expression is
not completely understood (8,12), but post-translational
modifications in histone H3 lysine 9 (H3K9) play a key
role in determining and transmitting the expression state
of clonally variant genes, similar to stochastic gene expres-
sion processes in higher eukaryotes (13). Acetylation at this
position (H3K9ac) is associated with the active state of P.
falciparum clonally variant genes, whereas tri-methylation
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(H3K9me3) is associated with their silenced state (7,14–
19). Clonally variant genes are located in bistable chromatin
domains, such that once established both the euchromatin
(active) and the heterochromatin (silenced) states are sta-
ble and clonally inherited (16). Since the epigenetic trans-
mission of chromatin states is less faithful than DNA repli-
cation, spontaneous transitions between the two chromatin
states occur, albeit at low frequency, resulting in switches
between the active and repressed transcriptional states.
The regulation of two of the P. falciparum gene fam-
ilies under clonally variant expression involves an addi-
tional layer of complexity: mutually exclusive expression.
This phenomenon implies that an individual cell only ex-
presses one gene of the family at a time. This type of regula-
tion has been studied for gene families such as olfactory re-
ceptor genes and protocadherins in higher eukaryotes (20),
and for genes linked to antigenic variation in protozoan
parasites such as Trypanosoma brucei or Giardia lamblia
(21), among others. Different gene families use disparate
molecular mechanisms to achieve mutual exclusion. The
two gene families under mutually exclusive expression in P.
falciparum are var and cytoadherence-linked asexual gene 3
(clag3) (8). var genes, a large family of about 60 genes per
genome, encode the P. falciparum exported membrane pro-
tein 1 (PfEMP-1). This protein is exported to the infected
erythrocyte surface, where it participates in two processes
linked to malaria virulence: antigenic variation and cytoad-
herence (22).
In contrast to the large var family, there are only two
clag3 genes, clag3.1 and clag3.2 (PF3D7 0302500 and
PF3D7 0302200, respectively, previous IDs PFC0120w and
PFC0110w), which show ∼95% sequence identity and are
located only 10 kb apart from each other. These genes are
part of the five-member clag family, which also includes the
more distantly related genes clag2, clag8 and clag9 (23).Mu-
tually exclusive expression only affects the two clag3 genes,
such that an individual parasite expresses either clag3.1
or clag3.2, whereas clag2 undergoes independent clonally
variant expression and clag8 and clag9 appear to be ex-
pressed in all parasites (24). Mutually exclusive expression
of clag3 genes has now been observed by several differ-
ent laboratories in parasite lines of different genetic back-
grounds (16,17,24–26), and also in parasites in which a re-
combination event resulted in the presence of three clag3
genes (26) or in transgenic parasites where the clag3.2ORF
was disrupted by insertion of a selectable marker (17). Sim-
ilar to other clonally variant genes, silencing of one of the
clag3 genes is mediated by H3K9me3-based heterochro-
matin, whereas activation is associated with an increase
in the alternative modification at this position, H3K9ac
(16,17). Additionally, silencing of clag3 genes is associated
with a different position for specific nucleosomes and in the
case of clag3.2 also reduced accessibility to restriction en-
zymes, which is consistent with a heterochromatic confor-
mation (16).
The proteins encoded by clag3 genes, CLAG3s (also
known as RhopH1/CLAG3), play a fundamental role in
parasite biology by determining solute transport at the
infected erythrocyte membrane (25). Ions, nutrients, and
also certain toxic compounds with antimalarial activity re-
quire CLAG3 for their transport into infected erythrocytes
(9,10,25–27). However, a role for CLAG proteins in cytoad-
herence or erythrocyte invasion had been previously pro-
posed. Whether CLAGs actually participate in these pro-
cesses in addition to their established role in solute trans-
port remains to be determined (23). In any case, the tempo-
ral expression pattern of this gene family is intriguing: all
clag genes are expressed late in the asexual cycle (schizont
stage), but CLAG3 proteins only reach the infected erythro-
cytemembrane and participate in solute transport after sch-
izont bursting and reinvasion, about 20 h post-invasion in
the following cycle of asexual growth (25). Another unre-
solved question is why parasites express only one clag3 gene
at a time. Recent investigations have revealed functional dif-
ferences in the transport of some solutes between parasites
expressing CLAG3.1 or CLAG3.2, which is suggestive of a
role for mutually exclusive expression of these genes in re-
stricting the entrance of specific solutes (9). An alternative
possible role for mutual exclusion of clag3 genes is immune
evasion: although this gene family is apparently too small
to mediate effective antigenic variation, variant expression
and genetic polymorphism may play synergistic roles to es-
cape immune responses (28).
While the products of both var and clag3 genes play fun-
damental roles in parasite biology, only mutually exclusive
expression of var has been extensively studied (8,12,29).
Mutually exclusive expression of var genes is controlled
by two genetic elements, the var upstream region includ-
ing the main promoter and the var intron including a sec-
ond promoter (30–32). Small genetic elements that mediate
promoter-intron pairing and the mutual exclusion element
at the var upstream region are necessary for varmutually ex-
clusive expression (33,34). Furthermore, several chromatin
regulators have been identified that play specific roles in var
mutual exclusion, including sirtuins, SET domain methyl-
tranferases, and the histone variants H2A.Z andH2B.Z (re-
viewed in ref. (12)).
We have previously characterized the clag3 promoters
and found that in transient transfection assays episomal
clag3 promoter activity is independent of the endogenous
clag3 gene being expressed (16). However, in these assays
only a small fraction of the parasites carry the transfected
plasmid (transfection efficiency ∼10−6), making it impos-
sible to determine how the episomal clag3 promoter af-
fects expression of endogenous clag3 genes. To unravel the
‘rules’ that govern mutually exclusive expression of clag3
genes, here we used transgenic parasite lines with additional
clag3 promoters driving the expression of reporter genes or
selectable markers, either in stable episomes or integrated
next to the endogenous clag3 loci. We also investigated the




Plasmids 3.2–1371-LH and 3.2-LH-bsdR (previously
named 3.2–1371-LH-bsdR) have been described before
(9,16). Plasmids 3.2-LH-bsd and ama1-LH-bsd were
generated by adding the blasticidin S (BSD) deaminase re-
sistance cassette from plasmid pHBupsCR (32) to plasmids
3.2–1371-LH or ama1–1570-LH (16), respectively. This was
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achieved by inserting a PstI-SmaI fragment of pHBupsCR,
treated with T4 DNA polymerase to generate blunt ends,
into a SmaI site in the 3.2–1371-LH or ama1–1570-LH
plasmids. Plasmid pHBc3.2 was derived from pHBupsCR
(32) by replacing the upsC promoter and rep20 sequences
with the clag3.2 upstream region (full 5′ intergenic re-
gion). The clag3.2 promoter was amplified by polymerase
chain reaction (PCR) with primers Prom3.2fPst and
Prom3.2rBam (Supplementary Table S1), digested with
PstI and BamHI, and inserted into the pHBupsCR plasmid
digested with the same enzymes.
Parasites
The 3D7-A stock of the clonal parasite line 3D7 and 3D7-A
subclones 10G and 1.2B have been previously described and
characterized (24,35,36). Parasites were cultured in B+ ery-
throcytes under standard conditions with media contain-
ing Albumax II and no human serum. Cultures were typ-
ically synchronized by sorbitol lysis, which eliminates ery-
throcytes infected with parasites at the trophozoite or sch-
izont stages. Synchronization of the parasite line 10G-0.6–
2, which is resistant to sorbitol lysis (9), was performed us-
ing either magnetic columns to purify erythrocytes infected
with parasites at mature stages (experiments to analyze ex-
pression of a ncRNA) or by treatment with L-Proline (to
synchronize 10G-0.6–2 and control 10G cultures for his-
tone modifications analysis). In brief, L-Proline lysis was
performed using a procedure similar to sorbitol lysis, but
treating cultures for 7 min at 37◦C with a L-Proline solu-
tion (seven pellet volumes) instead of sorbitol. The concen-
tration of L-Proline used ranged from 280 mM in initial ex-
periments to 150 mM in later experiments to minimize the
effects of the treatment on the viability of the cultures. For
selected experiments, parasites were tightly synchronized to
a defined age window by purification of parasites at the sch-
izont stage (using Percoll gradient) followed by sorbitol ly-
sis 5 or 7 h later. Transfection was performed by electropo-
ration according to standard procedures (37). To select for
parasites stably carrying the plasmids, transfected cultures
were selected with BSD at 2.5 g/ml and to select for para-
sites that integrated the plasmid we additionally performed
two off/on drug cycles. Other drug selection experiments
used BSD at the same concentration or 10 nM WR99210
unless otherwise stated. Subcloning was performed by lim-
iting dilution. In the case of parasites with an integrated
plasmid (pHBc3.2), subcloning was performed in the ab-
sence of any drug. Luciferase assays on transiently or sta-
bly transfected parasites were performed as previously de-
scribed (16).
Transcriptional analysis
Transcriptional analysis by reverse-transcriptase quantita-
tive PCR (RT-qPCR) was performed on synchronized cul-
tures at the schizont stage unless otherwise stated. RNAwas
obtained using the Trizol method, DNAse treated, column
purified and reverse transcribed as previously described
(24). Reverse transcription was performedwith amixture of
random primers and oligo (dT). cDNAs were analyzed by
qPCR with the Power SYBR Green Master Mix (Applied
Biosystems), using the standard curve method. In brief,
each plate included a standard curve consisting of five se-
rial 1:10 dilutions of gDNA for each primer pair. All plates
also included–RT controls for each sample and no template
controls for each primer pair. All samples and controls were
analyzed in triplicate. Results for test samples were obtained
by interpolating the Ct value in the standard curve and nor-
malized against expression values for control genes with a
similar temporal expression pattern. This approach corrects
for differences in parasite age between RNA preparations
from different cultures. Unless otherwise stated, rhoph2 (ID
PF3D7 0929400) was used to normalize the expression of
genes under the control of schizont-specific promoters (such
as clag3 promoters) and seryl tRNA synthetase (serrs, ID
PF3D7 0717700) was used to normalize the expression of
genes under the control of promoters expressed at similar
levels throughout the asexual blood cycle, or to investigate
the stage of expression. The gDNA used for the standard
curve was typically from the same parasite line under tran-
scriptional analysis. In the case of stably transfected para-
site lines (episomal or integrated plasmids), using this ap-
proach implies that transcript levels indicate the activity
of one copy of the transgene (average of expression of all
copies). When the same gDNA standard curve was used
to analyze transgenic parasite lines with different plasmid
copy number, results for the genes in the plasmid were ad-
justed by plasmid copy number relative to the parasite line
used for the standard curve. The primers used for RT-qPCR
analysis are described in Supplementary Table S1.
Genetic analysis
gDNA for qPCR or Southern blot analysis was prepared
by sodium dodecyl sulphate (SDS) lysis followed by dou-
ble phenol–chloroform extraction and ethanol precipita-
tion. Integrated or episomal plasmid copy number relative
to the gDNA used for the standard curve (gDNA from one
of the transgenic lines analyzed) was determined by qPCR
using the standard curve method as in the transcriptional
analysis. Southern blot analysis was performed as previ-
ously described (16). The primers used to amplify the probes
for Southern blot are described in Supplementary Table S1.
Chromatin immunoprecipitation (ChIP)
Chromatin was obtained from saponin-extracted para-
sites at the late trophozoite or schizont stage, cross-linked
with formaldehyde and sonicated as previously described
(11,16). For the experiments in Supplementary Figure S5
we used the chromatin immunoprecipitation (ChIP) proce-
dure previously described, with Magna ChIPTM Protein G
magnetic beads (Merck-Millipore) andmagnetic separation
(11) instead of agarose beads and centrifugation (16). For
these experiments we used antibodies fromMillipore (#07–
442 and #07–352) (16) that have been widely used for ChIP
in malaria research, including ChIP–chip experiments (19).
For the experiments presented in Figure 4, we immuno-
precipitated chromatin (prepared as described above) us-
ing the MAGnifyTM Chromatin Immunoprecipitation Sys-
tem (Life Technologies) and antibodies against H3K9me3
and H3K9ac fromDiagenode (pAb-193–050 and pAb-004-
050, respectively). This newprocedure described here results
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in highly improved signal to noise ratios. In all cases, im-
munoprecipitates were analyzed by qPCR using the stan-
dard curve method, with the primers detailed in Supple-
mentary Table S1.
RESULTS
Activity of a clag3 promoter controlling a reporter gene in
stable episomes
To study the expression of a clag3 promoter in stable epi-
somes, we first designed the 3.2-LH-bsdR plasmid (9) (Fig-
ure 1A), which contains the clag3.2 promoter region (full 5′
intergenic region) controlling the expression of a luciferase
(luc) reporter gene and a BSD resistance cassette consist-
ing of the BSD deaminase gene (bsd) under the control of
the constitutive hsp90 (ID PF3D7 0708400) promoter. This
plasmid also contains the subtelomeric repeat sequence
rep20 that improves plasmid segregation (38). We first used
a transient transfection assay to compare luciferase expres-
sion between parasites transfected with this plasmid or an
equivalent plasmid without the BSD resistance cassette and
rep20 element (plasmid 3.2–1371-LH, Figure 1A) (16). The
plasmid 3.2-LH-bsdR showed lower luciferase activity (Fig-
ure 1B), indicating that the clag3.2 promoter is partially si-
lenced in this plasmid. This is not explained by the presence
of the rep20 element because we have previously demon-
strated that addition of this element increases luciferase ac-
tivity in 3.2–1371-LH (16). Hence, partial repression of the
clag3 promoter in plasmid 3.2-LH-bsdR is likely to be a
consequence of the presence of a second promoter (the con-
stitutive hsp90 promoter). This situation is reminiscent of
observations with var promoters, which require the intron
or an alternative paired promoter for transcriptional silenc-
ing (30,39,40). However, silencing in 3.2-LH-bsdR may be
a consequence of the specific plasmid architecture, as sug-
gested by experiments presented below.
Next we transfected two subclones of the parasite line
3D7-A, termed 10G and 1.2B, with the plasmid 3.2-LH-
bsdR and applied BSD selection to obtain populations
stably carrying the plasmid. 10G and 1.2B predominantly
express clag3.2 or clag3.1, respectively (16,24). Consistent
with previous observations from experiments using tran-
sient transfection (16), luciferase assays revealed similar
clag3.2 promoter activity between the two stably trans-
fected lines (Figure 1C), confirming that expression of epi-
somal clag3 promoters is independent of which endogenous
clag3 is active. This result suggests that expression of one
or the other clag3 gene does not depend on differentially-
expressed trans-acting factors. However, luciferase assays
do not inform about the activity of the episomal clag3.2 pro-
moter relative to the activity of endogenous clag3 promot-
ers. Hence, we performed a transcriptional analysis of the
stably transfected 10G line using RT-qPCR. We found that
expression of the episomal luc gene was much lower than
expression of endogenous clag3 genes (Figure 1D), indicat-
ing that the clag3.2 promoter in the stable episome is pre-
dominantly silenced. We obtained subclones of 10G stably
transfected with plasmid 3.2-LH-bsdR and analyzed their
luc expression, but these experiments did not conclusively
determine whether the episomal clag3.2 promoter under-
goes clonally variant expression or is homogeneously ex-
pressed at low levels in this transgenic parasites population
(Supplementary Figure S1).
To determine whether the low transcriptional activity of
the episomal clag3.2 promoter is attributable to an intrin-
sic ability to nucleate heterochromatin, we conducted a new
series of experiments using the plasmids 3.2-LH-bsd (iden-
tical to 3.2-LH-bsdR except for the absence of the rep20 ele-
ment) and ama1-LH-bsd (Figure 1A). In the latter plasmid,
the clag3.2 upstream region is replaced by the upstream re-
gion (1570 bp) of ama1, which is not prone to heterochro-
matin formation or clonally variant expression and is ex-
pressed at the schizont stage in all parasites (7,19). Sta-
ble transfection of 10G and 1.2B with these plasmids fol-
lowed by transcriptional analysis revealed that both pro-
moters driving luc expression (clag3.2 and ama1) are largely
silenced in the episome compared with their chromosomal
counterparts, which indicates that silencing is independent
of the presence of a clonally variant promoter (Figure 1E).
Hence, low expression of the promoters in these plasmids
is mainly attributable to the episomal status or the specific
plasmid architecture and does not seem to depend on mu-
tual exclusion of clag3 promoters or the ability to nucleate
heterochromatin. While this result was unexpected, low ex-
pression from an episomal promoter compared to a chro-
mosomal copy of the same promoter has been previously
observed by others (41). It is difficult to estimate if this oc-
curs commonly in malaria episomal expression systems be-
cause in the majority of published articles transcript levels
are not compared between a transgene and the endogenous
gene controlled by the same promoter.
Total expression of endogenous clag3 genes was similar
between parasite lines stably transfected with the 3.2-LH-
bsdR plasmid and untransfected 10G and 1.2B parasites.
Likewise, total endogenous clag3 expression was also sim-
ilar between parasites transfected with minus rep20 plas-
mids containing either a clag3.2 promoter or an ama1
promoter (Figure 1F). However, stably transfected 10G
cultures switched to different extents from predominant
clag3.2 expression to a mixed population of parasites ex-
pressing one or the other clag3 gene, independently of the
presence or absence of the episomal clag3.2 promoter. Par-
asites that express CLAG3.1 limit the transport of BSD
across the infected erythrocyte membrane and in the pres-
ence of this drug have a survival advantage over those that
express CLAG3.2 (9), which explains the progressive elim-
ination of CLAG3.2-expressing parasites in BSD selected
cultures. In any case, the low level of transcriptional activ-
ity of the episomal promoters precludes determining from
these experiments whether a fully active episomal clag3
promoter would affect the expression of endogenous clag3
genes.
Activation of an episomal clag3 promoter does not result in
silencing of endogenous clag3 genes
To determinewhether an active episomal clag3 promoter in-
filtrates the clag3mutual exclusion program, resulting in si-
multaneous silencing of the two endogenous clag3 genes, we
designed a new plasmid where a clag3.2 promoter controls
the expression of the selectable marker hdhfr, which confers
resistance to the drug WR99210 (plasmid pHBc3.2, Fig-
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Figure 1. Characterization of clag3 promoters driving expression of a luciferase gene in stable episomes. (A) Schematic of the plasmids used in this study
with a clag3 promoter controlling a luc gene (not to scale). Note that the hsp90 (ID PF3D7 0708400) promoter is referred to as hsp86 promoter in many
previous publications. (B) Transient transfection luciferase assays of 3D7-A with plasmids 3.2–1371-LH and 3.2-LH-bsdR. Luciferase activity was mea-
sured in parasites at the schizont stage. Results are normalized to 1% parasitemia and expressed in relative light units (RLU). Values are the average of two
independent biological replicates each performed in duplicate plates, with SEM. (C) Luciferase activity in 10G and 1.2B parasite lines stably transfected
with plasmid 3.2-LH-bsdR. Cultures were synchronized to a 0–5 h age window and harvested for luciferase assays 40 h later (40–45 h post invasion).
Results are normalized to 1% parasitemia and expressed as RLU in 1.2B relative to 10G. Values are the average of two independent biological replicates
each performed in duplicate plates, with SEM. (D) RT-qPCR transcriptional analysis (schizont stage) of the 10G line stably transfected with plasmid
3.2-LH-bsdR. Transcript levels were normalized against rhoph2. Since we used a qPCR standard curve consisting of gDNA of the same parasite line as
the test samples, expression levels for the episomal gene reflect expression per copy of the gene (average of all copies, see ‘Materials and Methods’ section).
Values are the average of three independent biological replicates, with SEM. (E) Transcriptional analysis of 10G and 1.2B cultures (schizont stage) stably
transfected with plasmids 3.2-LH-bsd or ama1-LH-bsd (‘3.2’ and ‘ama1’, respectively). Values are the average of two independent biological replicates,
with SEM. (F) Expression of endogenous clag3 genes in 10G and 1.2B cultures transfected with plasmid 3.2-LH-bsdR (‘3.2-R’) or minus rep20 plasmids
‘3.2’ and ‘ama1’(as in panel E). Expression of clag3 genes in untransfected 10G and 1.2B cultures (‘UNTR.’) is shown for comparison. Each series of
experiments is shown in a separate bar chart. Values are the average of two or three independent biological replicates, with SEM.
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ure 2A). This plasmid also contains a BSD resistance cas-
sette under the control of the constitutive hsp90 promoter.
10G cultures were transfected with pHBc3.2 and selected
with BSD to obtain a population of parasites stably carry-
ing the plasmid. We then maintained these cultures for 3
weeks either in the presence of BSD alone or in the pres-
ence of BSD plus 10 nM WR99210 to select for parasites
in which the hdhfr gene was active. These cultures were ini-
tially sensitive to WR99210, consistent with a silenced state
of the episomal clag3.2 promoter, but a resistant population
was apparent after about 1 week of WR99210 selection. On
a technical note, this result demonstrates that the hdhfr gene
under the control of a promoter expressed only at the sch-
izont stage can efficiently mediate drug resistance.
The two genes in the episome, hdhfr and bsd, were ex-
pressed at low levels in the absence of WR99210, but tran-
script levels increased dramatically for both genes after se-
lection with the drug (Figure 2B). However, the increase
in transcript levels was paralleled by an increase in plas-
mid copy number. When transcript levels were normalized
by the relative plasmid copy number, it was apparent that
transcriptional activation was only about three-fold (Fig-
ure 2C). Hence, WR99210 pressure selected for parasites
with both higher plasmid copy number and plasmids that
were transcriptionally more active. These results indicate
that the full plasmid, including the constitutive promoter
driving bsd expression, is by default partly silenced. Im-
portantly, total levels of endogenous clag3 transcripts did
not decrease inWR99210-selected parasites, demonstrating
that activation of an episomal clag3.2 promoter does not
preclude expression of the endogenous clag3 genes (Figure
2D). Instead, total endogenous clag3 transcript levels were
slightly higher in the presence of WR99210, and the switch
from clag3.2 to clag3.1 expression was less pronounced in
the presence of this drug. The explanation for this observa-
tion is that the increased plasmid copy number and the tran-
scriptional activation of the full plasmid associated with
WR99210 selection leads to a large increase in bsd transcript
levels, which confers efficient BSD resistance and limits the
selective advantage of parasites with clag3 expression pat-
terns that restrict BSD transport. Altogether, these results
provide the first evidence, to our knowledge, that more than
one clag3 promoter can be simultaneously active.
A chromosomal clag3 promoter driving the expression of a
selectable marker is silenced by default but mutually exclusive
expression is relieved under strong selective pressure
To characterize an additional copy of a clag3 promoter in
a chromosomal context, integrated next to the endogenous
clag3 loci, we transfected 3D7-A parasites with the plasmid
pHBc3.2 (Figure 2A) and used on/off BSD cycles to se-
lect for parasites that had integrated the plasmid. Southern
blot analysis revealed integration of multiple copies of the
plasmid by single homologous recombination with the en-
dogenous clag3.2 upstream region (Figure 3A and Supple-
mentary Figure S2). In spite of several attempts, we failed
to obtain parasites with a single copy of the plasmid inte-
grated. Transcriptional analysis of the transgenic line be-
fore subcloning revealed that the hdhfr gene controlled by
the extra copies of the clag3.2 promoter was silenced (Fig-
ure 3B), which is consistent with mutually exclusive expres-
sion of clag3 promoters. While the parental 3D7-A popu-
lation contains a similar proportion of parasites expressing
clag3.1 or clag3.2, themajority of parasites in the transgenic
line expressed clag3.1 (Figure 3B), as expected after hav-
ing used BSD for selection (9). Nonetheless, we were still
able to identify subclones of this transgenic line (Supple-
mentary Figure S2) that predominantly express clag3.1 (G9
subclone) or clag3.2 (C5 subclone) (Figure 3C).
When C5 and G9 were maintained in the absence of any
drug for 3 weeks, the additional clag3.2 promoters driv-
ing hdhfr expression were silenced in both subclones (Fig-
ure 3C). Consistently, these subclones were initially highly
sensitive to WR99210, but a population of resistant para-
sites emerged after a few cycles of drug selection. C5 andG9
cultures selected for 3 weeks withWR99210 expressed hdhfr
at high levels, indicating that in the selected parasite popu-
lations at least some of the copies of the additional clag3.2
promoters are in an active state (Figure 3C). Note that the
clag3.2 promoter is weaker than the clag3.1 promoter, such
that in a transcriptionally homogeneous parasite line ex-
pressing clag3.2, total clag3 transcript levels are lower than
in a line expressing clag3.1 (Figures 1F and 3C), as previ-
ously observed (9,16). Importantly, we ruled out changes in
gene copy number as a mechanism for the increased hdhfr
transcript levels observed after WR99210 selection (Sup-
plementary Figure S3). Thus, in contrast to experiments
with episomal plasmids (Figure 2), transcript level changes
associated with drug selection in parasites with chromo-
somal extra copies of a clag3 promoter are exclusively at-
tributable to dynamic epigenetic changes. Of note, the trans-
genic promoters displayed correct temporal expression pat-
terns across the asexual blood cycle (Supplementary Figure
S4), confirming their physiological functionality.
The activation of the additional clag3.2 promoters did
not lead to silencing of the endogenous clag3 genes in ei-
ther of the subclones (Figure 3C). This result unambigu-
ously demonstrates that under selective pressure more than
one clag3 promoter can be simultaneously expressed. The
bsd gene, driven by a constitutive promoter not susceptible
to clonally variant expression or heterochromatin forma-
tion (7,19,42) and located between hdhfr and endogenous
clag3.2, was silenced in the absence of drugs in G9, where
both neighbor genes are silenced. In contrast, bsd was ex-
pressed at much higher levels in C5, where hdhfr is silenced
but endogenous clag3.2 is active (Figure 3C). The low level
of bsd expression in the unsubcloned transgenic population
(Figure 3B) reflects the predominance of clag3.1 expressing
parasites (G9-like) before subcloning. After WR99210 se-
lection bsd transcript levels increased >10-fold in G9, but
they were still lower than in C5 (Figure 3C). However, bsd
expression driven by the hsp90 promoter was always lower
than expression of endogenous hsp90 (Figure 3B), suggest-
ing that only one or a few of the integrated copies of the
hsp90 promoter driving bsd expression are active in the C5
orWR99210-selected G9 lines. Note that in our analysis ex-
pression levels reflect expression per copy of the transgene
(average of all copies, see ‘Materials andMethods’ section).
Silencing of a constitutive promoter by the influence of the
neighboring epigenetically-regulated genes is clearly sug-
gestive of spreading of repressive chromatin structures (see
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Figure 2. Characterization of clag3 promoters driving expression of a selectable marker in stable episomes. (A) Schematic of the plasmid pHBc3.2. (B)
Transcriptional analysis of 10G cultures (schizont stage) stably transfected with plasmid pHBc3.2 maintained in parallel for 3 weeks without or with
WR99210 (WR). All cultures were maintained in the presence of BSD. Transcript levels were normalized against rhoph2 for genes controlled by clag3
promoters or against serrs for bsd, which is controlled by a promoter expressed at all asexual stages. (C) Transcript levels in panel B adjusted by relative
plasmid copy number (ARPCN). (D) Expression of endogenous clag3 genes in the same cultures. In all panels, values are the average of four independent
biological replicates (except in panel C, n = 3 because relative plasmid copy number was not available for one of the experiments) from two independent
WR99210 selections, with SEM.
below). In fact, hdhfr activation in the presence ofWR99210
in G9 was accompanied not only by activation of the bsd
gene but also by a small increase in transcription of endoge-
nous clag3.2 (Figure 3C) consistently observed in three in-
dependent selection experiments.
Next wemaintainedWR99210-selected cultures for three
additional weeks either in the presence (‘+’ bars) or ab-
sence (‘+/−’ bars) of this drug. Parasites never exposed to
WR99210 were also grown and analyzed in parallel (‘−’
bars, Figure 3D). Removal of the drug resulted in reversal
of the changes associated with drug selection (Figure 3D).
Of note, hdhfr was almost completely silenced in both C5
and G9 by 3 weeks after removal of the drug, indicating
that simultaneous expression of multiple clag3 promoters
is only maintained under strong selective pressure and mu-
tual exclusion is restored after removing the pressure. Last,
treatment of C5 and G9 with BSD revealed that both para-
site lines are relatively insensitive to this drug, showing that
even the low levels of bsd expression in unselected G9 are
sufficient to enable growth in the presence of BSD (albeit
at reduced rates). Consequently, no major transcriptional
changes were observed after 3weeks of BSD selection, apart
frompartial activation of the bsd gene inG9 (Figure 3E). In-
terestingly, themoderate activation of bsd in G9was accom-
panied by a small but consistent increase in hdhfr transcript
levels (Figure 3E), confirming the inter-related chromatin-
based epigenetic regulation of the two neighbor loci.
Epigenetic silencing at the clag3 region is invariably mediated
by H3K9me3-based heterochromatin
We used ChIP analysis to directly determine whether silenc-
ing of the bsd gene in the G9 parasite line cultured in the
absence of any drug is mediated by H3K9me3-based hete-
rochromatin. The bsd gene driven by the constitutive hsp90
promoter is highly enriched in H3K9me3 and has low levels
of H3K9ac, similar to heterochromatin positive controls (a
var gene and clag3.2, which is silenced in this parasite line)
(Figure 4A). The ratio of acetylation to tri-methylation at
H3K9, which provides a more sensitive measure of the eu-
chromatic or heterochromatic state of a locus, clearly con-
firms that the bsd cassettes are in a heterochromatic state
in G9 (Figure 4A). Considering that the hsp90 promoter is
not clonally variant and does not carry epigenetic marks
of silencing in its endogenous location (7,19,42), this result
directly demonstrates spreading of heterochromatin from
neighbor loci (Figure 5). ChIP analysis of the G9 line se-
lected with WR99210 showed a pattern of H3K9 modifica-
tions similar to the unselected line (data not shown), consis-
tent with the idea that only some of the copies of the bsd cas-
sette are activated upon selection (Figure 3B and C). Given
that all integrated copies of the bsd cassette are identical, it
is impossible to analyze by ChIP the individual copies sep-
arately.
We also used ChIP analysis to determine whether simul-
taneous silencing of the two clag3 genes is mediated by
H3K9me3-based heterochromatin (Figure 4B and Supple-
mentary Figure S5). We and others have previously demon-
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Figure 3. Characterization of parasite lines with additional chromosomal clag3 promoters integrated in the vicinity of endogenous clag3 loci. (A) Schematic
(not to scale) of the clag3 loci in transgenic parasites that have integrated the pHBc3.2 plasmid by single homologous recombination with the clag3.2
upstream region. Genes or annotated ncRNAs are indicated by block arrows. The 5′ promoter regions of the genes analyzed are highlighted. The area in
brackets is the integrated plasmid, which is repeated several times because multiple copies are integrated (Supplementary Figure S2). (B) Transcriptional
analysis (schizont stage) of 3D7-A with integrated pHBc3.2 (unsubcloned population). Values are the average of two independent biological replicates,
with SEM. (C) Transcriptional analysis of C5 and G9 subclones selected for 3 weeks with WR99210 or grown in parallel in the absence of drug. Values
are the average of three independent biological replicates (independent drug selections), with SEM. The schematic indicates the active (green arrow) or
silenced (red cross) state of the genes in C5 and G9 under the different conditions tested. Activation of only some of the integrated copies (bsd gene) or
activation in only a small fraction of the parasites (endogenous clag3.2 promoter) is indicated by green arrow/red cross. It is likely that active expression
of hdhfr after WR99210 selection also occurs in only some of the copies of the integrated plasmid. (D) Transcriptional analysis of C5 and G9 transgenic
subclones grown in parallel for 6 weeks with no drug, with WR99210 or 3 weeks with WR99210 followed by 3 weeks without drug (+/− WR). Values
are the average of two independent biological replicates (independent drug selections), with SEM. (E) Transcriptional analysis of C5 and G9 transgenic
subclones grown in parallel for 3 weeks in the presence or absence of BSD. Results are the average of two independent biological replicates (independent
drug selections), with SEM.
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Figure 4. ChIP analysis of the clag3 loci in transgenic and BSD-selected parasite lines. (A) ChIP analysis of H3K9me3 and H3K9ac in the transgenic G9
parasite line (late trophozoite stage) grown in the absence of drug. ama1 and the var gene PF3D7 1240300 are euchromatin and heterochromatin controls,
respectively. Primers at the ORF of clag3.1 or clag3.2 (near the 5′ end, primer pair 5) were used for the analysis of clag3 genes. In this parasite line clag3.1
is expressed and clag3.2 is silenced; hence, these genes are additional controls for the euchromatic and heterochromatic states, respectively. The bsd loci
were analyzed with a forward primer at the hsp90 5′ region and a reverse primer at the bsd ORF (hsp90 5′-bsd) and with primers at the bsd ORF (bsd).
Results are expressed as percentage of immunoprecipitated chromatin relative to the input sample (% input). Results are also expressed as the ratio of %
input for H3K9ac divided by % input for H3K9me3. High values of this ratio indicate a euchromatic state, as in the ama1 control, whereas low values
indicate an heterochromatic state, as in the var control. Values are the average of two independent biological replicates, with SEM. (B) ChIP analysis of the
clag3 loci in the parasite line 10G (clag3.2 is expressed) and the BSD-selected line10G-0.6–2 (the two clag3 genes are silenced) at the schizont stage. For
each clag3 gene, primer pair 3 (P3) is near the transcription start sites whereas primer pair 5 (P5) is near the 5′ end of the ORF. Values are the average of
three independent biological replicates, with SEM. Both H3K9ac and H3K9me3 levels at the clag3.2 locus were significantly different between 10G and
10G-0.6–2 (P < 0.05 using a t-test). Similar results were obtained using a different protocol and alternative antibodies widely used for ChIP analysis of
malaria parasites (Supplementary Figure S5).
strated that toxic compounds that require CLAG3s to en-
ter infected erythrocytes can select for parasites in which
both clag3 promoters are simultaneously silenced (9,10).
Here we analyzed the 10G-0.6–2 line, in which both clag3
genes are silenced after selection with a high concentration
of BSD (9), and a 10G culture maintained in parallel with-
out BSD as a control. In 10G-0.6–2 the clag3.2 locus is en-
riched in H3K9me3 and shows low levels of H3K9ac, sim-
ilar to the heterochromatic control (var), whereas in 10G,
where clag3.2 is active, the opposite pattern is observed,
with H3K9me3 and H3K9ac levels similar to the euchro-
matic gene ama1. On the other hand, the levels ofH3K9me3
and H3K9ac were similar between 10G and 10G-0.6–2 at
the clag3.1 locus, which is silenced in both lines (Figure 4B
and Supplementary Figure S5). These results demonstrate
that the same mechanism based on H3K9me3 mediates si-
lencing of only one clag3 gene in unselected parasite popu-
lations (16,17) and simultaneous silencing of the two par-
alogous genes in cultures under strong selective pressure.
This is in contrast to the results for an analogous parasite
line developed at a different laboratory, for which double
clag3 silencing was proposed to operate via a different epi-
genetic mechanism involving reduced levels of activating hi-
stone marks, as observed here for H3K9ac, but not the het-
erochromatin mark H3K9me3 (10).
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Figure 5. Hypothetical model for chromatin nucleation and spreading at
clag3 promoters. In the transgenic subclone G9 grown in the absence of
any drug (−WR), where both the endogenous clag3.2 promoter and the
clag3.2 promoter controlling hdhfr are silenced, all copies of the hsp90 con-
stitutive promoter controlling bsd expression are repressed. However, one
or more copies of the hsp90 promoter are active in the C5 subclone (even in
the absence of any drug), likely including the copy that is closer to the en-
dogenous clag3.2 promoter (active in this subclone). Likewise, some copies
of the hsp90 promoter are active in G9 selected with WR99210 (+WR),
in which at least some of the flanking clag3.2 promoters controlling hd-
hfr expression are active. Considering that the hsp90 promoter sequence
does not have the ability to nucleate heterochromatin, and silencing of
clag3.2 promoters is mediated by H3K9me3-based heterochromatin, the
most plausible interpretation for these observations is that hsp90 silencing
is mediated by heterochromatin spreading from the adjacent loci. In sup-
port of this view, we directly observed the H3K9me3 mark at the silenced
bsd locus in G9 (−WR). The schematic shows the predicted chromatin
organization in the different parasite lines. Densely-packed nucleosomes
with pink tones represent heterochromatin, characterized by H3K9me3,
whereas spaced green nucleosomes represent transcriptionally-permissive
euchromatin. The pink arrows indicate the possible directions of hete-
rochromatin spreading.
Expression of the ncRNA PF3D7 0302400 correlates with
clag3.1 expression
ncRNAs play important roles in the regulation of gene ex-
pression in many eukaryotes, including P. falciparum (43).
Interestingly, the first published RNA-seq study in P. fal-
ciparum reported two ncRNAs in chromosome 3 and both
are located between the two clag3 genes (44). One of these
two ncRNAs corresponds to a var-pseudogene, whereas the
other, PF3D7 0302400 (previous ID PF03TR002, abbrevi-
ated TR2), is an authentic >1 kb long ncRNA transcribed
from the opposite strand than clag3 genes ((45) and unpub-
lished data available at PlasmoDB: ‘Sanger FRT’ dataset by
Otto et al.) (Figure 6A). Since published data indicates that
TR2 is predominantly expressed at the schizont stage (44),
similar to clag genes, we initially focused our analysis of
TR2 expression on this life cycle stage. In two independent
comparisons, we found that schizonts from parasite clones
expressing clag3.1 show much higher TR2 transcript levels
than isogenic clones that express clag3.2 (Figure 6B). Al-
though TR2 transcript levels are rather low, as occurs for
many intergenic long ncRNAs also in other species (46),
they are clearly within the limits of detection of RT-qPCR.
Additional support to the idea that TR2 expression in sch-
izonts correlates with clag3.1 expression came from the
analysis of non-transfected 10G parasites selected with in-
creasing BSD concentrations, which results in altered clag3
expression patterns (9). In parallel to the switch from pre-
dominant clag3.2 expression to predominant clag3.1 ex-
pression associated with selection with BSD at low con-
centrations, a dramatic increase in the levels of TR2 tran-
scripts was observed (Figure 6C). However, in parasites se-
lected with a high concentration of the drug (2 g/ml), in
which both clag3 genes are simultaneously silenced, TR2
is also silenced (Figure 6C). This result indicates that TR2
expression correlates with clag3.1 expression, rather than
with clag3.2 silencing. Furthermore, 10G parasites trans-
fected with a plasmid containing a BSD resistance cassette
and drug selected also increase TR2 expression (Figure 6C)
in parallel to their switch from clag3.2 to clag3.1 expres-
sion (9).
Next we performed a time-course analysis of TR2 ex-
pression in the 3D7 parasite stocks 3D7-A and 3D7-B (35)
and the 3D7-A subclones 10G and 1.2B (Figure 6D). Sch-
izonts (40–45 h) of the 3D7-A line, which consist of a mix-
ture of parasites expressing clag3.1 or clag3.2 (24), expresses
TR2 at levels intermediate between 10G and 1.2B, as ex-
pected. On the other hand, the vast majority of parasites in
the 3D7-B population express clag3.1 (24), and correspond-
ingly 3D7-B schizonts expresses TR2 at high levels similar
to 1.2B. These experiments also revealed expression of TR2
mainly in schizonts in 3D7-A and subclones, consistent with
previous data (44), but in 3D7-B high TR2 expression was
also observed in 10–15 h rings (Figure 6D). Of note, the
neighbor var pseudogene PF3D7 0302300 (Figure 6A) is
expressed in rings at much higher levels in 3D7-B than in
3D7-A or its subclones, where it is completely silenced (7).
These results suggest that TR2 expression in schizonts cor-
relates with clag3.1 expression, whereas expression of this
ncRNA in rings correlates with expression of the neighbor
var pseudogene.
DISCUSSION
Two different P. falciparum gene families show mutually ex-
clusive expression: var and clag3. In both gene families, ex-
pression switches involve in situ silencing and activation reg-
ulated at the epigenetic level in the absence of DNA rear-
rangements (8,16,24,47). Here we investigated for the first
time the basic properties of mutual exclusion in the clag3
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Figure 6. Transcriptional analysis of the ncRNA TR2 in parasite lines with different clag3 expression patterns. (A) Schematic of the clag3 loci with the
var pseudogene PF3D7 0302300 (var ps.) and the ncRNA PF3D7 0302400 (TR2) between the two clag3 genes. The position of the primers used for the
transcriptional analysis of TR2, primer pairs A (PA) and B (PB), is indicated. (B) RT-qPCR comparison of TR2 transcript levels (relative to rhoph2)
in schizonts of the isogenic wild-type subclones 10G and 1.2B (left), or the transgenic subclones C5 and G9 (right). The expression status of clag3.1
and clag3.2, as determined here or previously (16,24), is indicated. Values are the average of three independent biological replicates, with SEM. TR2
transcript levels were significantly higher in parasite lines that express clag3.1 than in those that express clag3.2 (P < 0.05 using a paired t-test). (C) TR2
expression at the schizont stage in cultures of the 10G subclone grown in the absence of drugs (Ø) or selected with BSD at the concentrations indicated (in
g/ml). The bar chart on the right shows the comparison between untransfected 10G and a 10G culture transfected with plasmid BsdR (containing a bsd
selectable marker under the control of a constitutive promoter) and maintained under BSD selection for 8 weeks (9). The clag3 expression status indicated
for each selected or control line was previously determined (9). Values are the average of reactions performed in triplicate, with SEM. (D) Time-course
analysis of TR2 expression at different stages of the asexual life cycle (indicated in hours post-invasion). The expression status of clag3 genes and the var
pseudogene PF3D7 0302300 in each parasite line has been determined before (7,24). Values are the average of reactions performed in triplicate, with SEM,
and representative of independent technical or biological replicates.
gene family and unexpectedly found that mutually exclusive
expression of clag3 genes is strongly favored but is not strict.
We also gained insight into the molecular mechanisms con-
trolling this type of expression.
First we interrogated the system by introducing an addi-
tional clag3 promoter in a stable episome. To obtain para-
sites stably carrying the episome we used the bsd selectable
marker and selection with BSD, a drug to which parasites
can acquire resistance either via the bsd transgene or via
changes in endogenous clag3 expression (9,10). We found
that three separate but inter-related mechanisms shaped
transcript level patterns in this system: changes in the ex-
pression of endogenous clag3 genes to restrict drug access,
changes in episome copy number and transcriptional regu-
lation of the genes in the episome. The relative use of the dif-
ferent mechanisms varied between the different transgenic
lines and reflected dynamic selection of parasites, compli-
cating the interpretation of the results. Furthermore, we
found that some plasmids containing two expression cas-
settes are prone to transcriptional silencing independently
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of the presence of a clonally variant promoter able to drive
heterochromatin formation. In spite of these difficulties, we
could unambiguously determine that active expression of
an episomal clag3 promoter (under selective pressure) does
not preclude expression of endogenous clag3 genes. This is
in contrast to the var family, for which activation of epi-
somal var regulatory regions can result in silencing of all
endogenous var genes (31,32,48). Our results for episomal
clag3 promoters are more similar to the results of a recent
study that analyzed expression in an episomal context of
promoters from the clonally variant gene families rif, stevor,
pfmc-2tm and phist (48). Active transcription from episomal
promoters of these gene families did not repress the expres-
sion of endogenous members of the respective families, as
expected for gene families that are clonally variant but are
not subject tomutually exclusive expression.However, these
promoters were reported to be active by default in an epi-
somal context (48), in contrast to observations for episomal
clag3 promoters in our transgenic lines. Nonetheless, these
results are not directly comparable to ours because in that
study the transcriptional state of the episomal promoters
was not defined based on comparison with the endogenous
promoters.
To overcome the problems associated with episomal con-
structs, we integrated a construct containing a clag3 pro-
moter driving the expression of a selectable marker in the
parasite genome, next to the endogenous clag3 loci. In this
system the integrated plasmid is stable in the absence of
selection so we could avoid the constant use of BSD and
the effects of this drug on endogenous clag3 expression.
In this transgenic parasite line the additional chromosomal
clag3 promoters are silenced by default, a pattern consistent
with mutually exclusive expression, but using drug pressure
(WR99210) we could select for parasites in which they are
activated. Importantly, activation of the additional clag3
promoters did not affect the expression of endogenous clag3
genes. Hence, again in contrast to analogous experiments
with var genes (31,32), our results demonstrate that under
selective pressure clag3 promoters can break mutually ex-
clusive expression, although this occurs only transiently be-
cause expression of a single clag3 promoter is quickly re-
covered after removing the selective pressure. These findings
indicate that mutually exclusive expression of clag3 genes is
not strict, such that parasites that simultaneously express
more than one clag3 promoter can exist, but mutual ex-
clusion is strongly favored. We and others have previously
demonstrated that parasites that keep the two clag3 pro-
moters simultaneously silenced can also exist but recover
expression of a single clag3 gene after removing selective
pressure (9,10). Based on all of these observations, we pro-
pose a scenario where probabilistic molecular interactions
that remain to be characterized favor expression of a single
clag3 gene, but other expression patterns are possible and
occur at low frequency within parasite populations. Under
strong selective pressure favoring survival of parasites ex-
pressing none or more than one clag3 promoters, such par-
asites can be selected and become predominant in the pop-
ulation. However, the erythrocyte permeability phenotypes
resulting from these expression patterns may have a fitness
cost in the absence of selection, in addition to not being fa-
vored by regulatory mechanisms. While the characteristics
of mutual exclusion appear to be different between clag3
and var genes, it is possible that the scenario proposed for
clag3 may also apply for var. var mutual exclusion may be
more strict because of the role of this gene family in immune
evasion, but it is important to note that there are examples
of wild-type parasites expressing more than one var gene si-
multaneously (49–51). Furthermore, absence of PfEMP-1
expression does not pose a fitness cost for the parasite un-
der culture conditions, whereas absence of CLAG3 results
in severely reduced growth (9). This could explain why drug
pressure in transgenic parasites with a var promoter con-
trolling a drug resistance gene selects for parasites in which
all endogenous var genes are silencedwhereas analogous ex-
periments with a clag3 promoter select for parasites express-
ingmore than one clag3 promoter simultaneously, although
these different results may also be explained by amore strict
regulation of mutual exclusion in var.
The clag3 regulatory region used in our transgenic lines
(the full clag3.2 5′ intergenic region) confers correct tem-
poral regulation of expression (Supplementary Figure S4
and ref. (16)) and appears to be sufficient to mediate tran-
scriptional silencing, indicating that clag3 promoters play a
predominant role in controlling the expression of this gene
family. In our first set of experiments with clag3 promoters
in an episomal context we could not establish whether the
default state of extra copies of clag3 promoters is silenced,
because some plasmids with two promoters appear to be
largely silenced independently of the presence of a promoter
with the ability to nucleate heterochromatin (Figure 1). This
may be attributable to plasmid architecture and/or to epi-
somal state. Evidence for a default silenced state for extra
copies of clag3 promoters comes from experiments using a
plasmid with a different organization (pHBc3.2, with the
clag3.2 promoter located downstream of the bsd expression
cassette), analogous to plasmids used to define the default
silenced state of var promoters (32) and similar to plas-
mids used to analyze other clonally variant promoters that
were reported to be active by default in these plasmids (48).
When pHBc3.2 is integrated in the genome, clag3.2 promot-
ers have the ability to nucleate heterochromatin that spreads
into neighbor genes (see below). These results support the
idea that clag3 promoters are sufficient to mediate tran-
scriptional silencing, but it is important to note that even in
the integrated construct each transgenic copy of the clag3.2
promoter is paired with another promoter. In the case of
var genes the intron (or an alternative paired promoter) is
necessary for a var promoter to enter the mutually exclu-
sive expression program, such that var promoters missing
this genetic element are active by default (30,39,40,52). We
cannot formally exclude the possibility that an analogous
as yet unidentified regulatory element is necessary for the
silencing of clag3 genes, and that the paired promoters in
our constructs mimic the role of this hypothetical element.
We also considered the possibility that expression of a func-
tional CLAG3 protein plays a role in the regulation of mu-
tual exclusion, but this is highly unlikely because a previ-
ous study demonstrated that a clag3.2 gene truncated at the
beginning of its ORF still enters the mutual exclusion pro-
gram and its activation precludes expression of clag3.1 (17).
This observation strongly indicates that mutually exclusive
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expression of clag3 genes is independent of protein produc-
tion, similar to var genes (31,32).
The actual counting mechanism that determines that one
and only one gene of a family under mutually exclusive ex-
pression is active in individual cells remains elusive even
for extensively studied gene families such as var or olfac-
tory receptors (8,20). However, some of the molecular fac-
tors that are necessary to maintain the silenced or the active
state have been identified for var genes (8,12), while the fac-
tors involved in clag3 regulation remain largely unexplored.
Given that var and clag3 are gene families of very different
size and encode proteins with very different biological func-
tions, it is possible that different mechanisms regulate mu-
tual exclusion in the two families. Here we found that clag3
epigenetic silencing relies on H3K9me3-based heterochro-
matin even in parasite lines where the two clag3 genes are
simultaneously silenced. This result suggests that clag3mu-
tual exclusion depends on unknown molecular interactions
that favor heterochromatin formation in all but one of the
clag3 promoters, but themechanism operates in a non-strict
manner that allows heterochromatin formation in alterna-
tive numbers of clag3 promoters (e.g. all) in small selectable
subpopulations of parasites. Additionally, we show that ex-
pression of the TR2 ncRNA, located between the two clag3
genes, correlates with expression of clag3.1. Future studies
will need to establish the direction of causality in the coor-
dinated expression of TR2 and clag3.1, as TR2 expression
may either be a cause or a consequence of clag3.1 expres-
sion. In model eukaryotes, ncRNAs are involved in the reg-
ulation of many epigenetic processes and in P. falciparum
antisense ncRNAs originating from var introns appear to
be involved in the regulation of var expression (53). Further-
more, ncRNAs originating from subtelomeric repeats near
the var loci have been identified and also proposed to par-
ticipate in var regulation (54,55), although this hypothesis
awaits experimental validation.
Our experiments with integrated constructs revealed that
a constitutive promoter (hsp90 upstream region controlling
the bsd selectable marker) can be silenced by spreading of
heterochromatin from the neighbor loci (Figure 5). While
the ability of H3K9me3-based heterochromatin to spread
into adjacent regions is well documented in other organisms
(56), this is to our knowledge the first direct demonstration
of this phenomenon in P. falciparum. Previous studies had
shown silencing of a constitutive promoter located next to
a var promoter in an episomal context, and increased tran-
scription from the constitutive promoter upon activation
of the neighbor var promoter (32). However, these results
could be explained by reversible heterochromatin forma-
tion and spreading, as proposed by the authors, or alter-
natively by changes in plasmid copy number or by silencing
related with episomal state. In contrast, we provide clear ev-
idence for heterochromatin spreading in a stable chromo-
somal context, with isogenic parasite lines with different
epigenetic states of neighbor genes providing appropriate
controls. Furthermore, our ChIP analysis directly demon-
strates that the heterochromatin mark H3K9me3 is present
in the silenced bsd gene, as expected if silencing occurs by
heterochromatin spreading. The genome of P. falciparum is
organized in small transcriptional units corresponding to
individual genes, such that euchromatin-heterochromatin
transitions at a clonally variant locus do not affect the state
of the neighbor genes (7,16,40,57). In the light of our results
demonstrating thatP. falciparum silenced chromatin has the
potential to spread into neighbor regions, the independent
regulation of endogenous neighbor clonally variant genes
implies the existence of barrier elements or insulators (58)
that limit the spreading of heterochromatin.
Altogether, our findings unravel some main features of
clag3 mutually exclusive expression. CLAG3 expression
patterns are shaped by a combination of the effects of
these proteins on parasite fitness and non-deterministic epi-
genetic mechanisms favoring expression of a single clag3
gene in a non-strict manner. These mechanisms appear to
operate by preventing heterochromatin-mediated silencing
in only one of the clag3 promoters. A stochastic mecha-
nism that results in expression of a single clag3 gene in the
vast majority of parasites but allows alternative patterns in
small selectable subpopulations of parasites can increase
the adaptability of parasite populations and broaden the
range of environmental challenges to which they can sur-
vive. Understanding mutually exclusive expression of clag3
genes is important per se because CLAG3 proteins play a
fundamental role in parasite biology, but the limited size of
this gene family also makes it an attractive model to study
conserved features of mutually exclusive gene expression, a
largely enigmatic phenomenon repeatedly observed in evo-
lution.
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